{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:51:52Z","timestamp":1790621512342,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jconrel.2023.07.063","type":"journal-article","created":{"date-parts":[[2023,8,4]],"date-time":"2023-08-04T12:09:13Z","timestamp":1691150953000},"page":"147-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Homotypic targeted nanoplatform enable efficient chemoimmunotherapy and reduced DOX cardiotoxicity in chemoresistant cancer via TGF-\u03b21 blockade"],"prefix":"10.1016","volume":"361","author":[{"given":"Nuannuan","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liuxiang","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaoxiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2023.07.063_bb0005","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jconrel.2022.06.039","article-title":"Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression","volume":"348","author":"Kim","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2023.07.063_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121799","article-title":"Evoking tumor associated macrophages by mitochondria-targeted magnetothermal immunogenic cell death for cancer immunotherapy","volume":"289","author":"Jiang","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.07.063_bb0015","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.2147\/IJN.S145799","article-title":"Prevention of doxorubicin-induced cardiomyopathy using targeted MaFgF mediated by nanoparticles combined with ultrasoundtargeted MB destruction","volume":"12","author":"Tian","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.07.063_bb0020","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1158\/1078-0432.CCR-17-3112","article-title":"A novel TGFb trap blocks CHEMOTHERAPEUTICSINDUCED TGF\u03b21 signaling and enhances their anticancer activity in gynecologic cancers","volume":"24","author":"Zhu","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2023.07.063_bb0025","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00210-019-01624-3","article-title":"Irbesartan suppresses cardiac toxicity induced by doxorubicin via regulating the p38-MAPK\/NF-\u03baB and TGF-\u03b21 pathways, N-S","volume":"392","author":"El-Said","year":"2019","journal-title":"Arch. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.07.063_bb0030","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.biopha.2014.09.010","article-title":"Robinin modulates doxorubicin-induced cardiac apoptosis by TGF-\u03b21 signaling pathway in Sprague Dawley rats","volume":"68","author":"Janeesh","year":"2014","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2023.07.063_bb0035","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm1613","article-title":"Endothelial-to-mesenchymal transition contributes to cardiac fibrosis","volume":"13","author":"Zeisberg","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2023.07.063_bb0040","doi-asserted-by":"crossref","first-page":"4207","DOI":"10.7150\/thno.48530","article-title":"A novel role of kallikrein-related peptidase 8 in the pathogenesis of diabetic cardiac fibrosis","volume":"11","author":"Du","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2023.07.063_bb0045","doi-asserted-by":"crossref","first-page":"2107791","DOI":"10.1002\/adfm.202107791","article-title":"Erythrocyte membrane camouflaged metal\u2013organic framework nanodrugs for remodeled tumor microenvironment and enhanced tumor chemotherapy","volume":"32","author":"Qiao","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2023.07.063_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114527","article-title":"TGF-\u03b21-activated cancer-associated fibroblasts promote breast cancer invasion, metastasis and epithelial-mesenchymal transition by autophagy or over-expression of FAP-\u03b1","volume":"188","author":"Huang","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.07.063_bb0055","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/bjc.2013.768","article-title":"Cancer-associated fibroblasts induce epithelial\u2013mesenchymal transition of breast cancer cells through paracrine TGF-\u03b2 signaling","volume":"110","author":"Yu","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2023.07.063_bb0060","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.actbio.2021.09.002","article-title":"Tumor-targeting pH\/redox dual-responsive nanosystem epigenetically reverses cancer drug resistance by co-delivering doxorubicin and GCN5 siRNA","volume":"135","author":"Yuan","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2023.07.063_bb0065","doi-asserted-by":"crossref","first-page":"204","DOI":"10.7150\/thno.13907","article-title":"P-glycoprotein mediates postoperative peritoneal adhesion formation by enhancing phosphorylation of the Chloride Channel-3","volume":"6","author":"Deng","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2023.07.063_bb0070","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/sj.leu.2400663","article-title":"Enhancement of mdr1 gene expression by transforming growth factor-b1 in the new adriamycin-resistant human leukemia cell line ME-F2\/ADM","volume":"11","author":"Utsunomiya","year":"1997","journal-title":"Leukemia"},{"key":"10.1016\/j.jconrel.2023.07.063_bb0075","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.7150\/thno.19542","article-title":"TGF\u03b21 promotes gemcitabine resistance through regulating the LncRNA-LET\/NF90\/miR-145 signaling Axis in bladder Cancer","volume":"7","author":"Zhuang","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2023.07.063_bb0080","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13045-020-00966-3","article-title":"Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment","volume":"13","author":"Andr\u00e9s","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2023.07.063_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2021.114697","article-title":"Targeting immunosuppression by TGF-\u03b21 for cancer immunotherapy","volume":"192","author":"Streel","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.07.063_bb0090","doi-asserted-by":"crossref","first-page":"7575","DOI":"10.3390\/ijms22147575","article-title":"TGF-\u03b2 signaling: from tissue fibrosis to tumor microenvironment","volume":"22","author":"Chung","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2023.07.063_bb0095","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1038\/nri2808","article-title":"The polarization of immune cells in the tumour environment by TGF\u03b2","volume":"10","author":"Flavell","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2023.07.063_bb0100","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.canlet.2020.05.001","article-title":"Loss of the proprotein convertase Furin in T cells represses mammary tumorigenesis in oncogene-driven triple negative breast cancer","volume":"484","author":"He","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2023.07.063_bb0105","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.7150\/thno.19987","article-title":"Biodegradable hollow mesoporous silica nanoparticles for regulating tumor microenvironment and enhancing antitumor efficiency","volume":"7","author":"Kong","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2023.07.063_bb0110","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.addr.2016.06.011","article-title":"Recent progress in development of siRNA delivery vehicles for cancer therapy","volume":"104","author":"Kim","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2023.07.063_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.734443","article-title":"RNA drug delivery using biogenic nanovehicles for cancer therapy","volume":"12","author":"Li","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2023.07.063_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121902","article-title":"Self-amplified ROS production from fatty acid oxidation enhanced tumor immunotherapy by atorvastatin\/PD-L1 siRNA lipopeptide nanoplexes","volume":"291","author":"Gao","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2023.07.063_bb0125","doi-asserted-by":"crossref","first-page":"53598","DOI":"10.1021\/acsami.0c13023","article-title":"Virus mimetic Shell-Sheddable chitosan micelles for siVEGF delivery and FRET-traceable acid-triggered release","volume":"12","author":"Zhang","year":"2020","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2023.07.063_bb0130","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.7150\/thno.34314","article-title":"Development of a biocompatible copolymer nanocomplex to deliver VEGF siRNA for triple negative breast cancer","volume":"9","author":"Zhao","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2023.07.063_bb0135","doi-asserted-by":"crossref","first-page":"20689","DOI":"10.1021\/acsami.9b04668","article-title":"pH-switchable coordinative micelles for enhancing cellular transfection of biocompatible Polycations","volume":"11","author":"Zhang","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2023.07.063_bb0140","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1021\/acs.nanolett.9b03817","article-title":"Cancer cell membrane-coated nanoparticles with a yolk-Shell structure augment cancer chemotherapy","volume":"20","author":"Nie","year":"2020","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2023.07.063_bb0145","article-title":"Recent advances in cell membrane-camouflaged nanoparticles for cancer phototherapy","volume":"15","author":"Zhen","year":"2019","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2023.07.063_bb0150","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.actbio.2013.10.037","article-title":"A tumoral acidic pH-responsive drug delivery system based on a novel photosensitizer (fullerene) for in vitro and in vivo chemo-photodynamic therapy","volume":"10","author":"Shi","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2023.07.063_bb0155","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.2147\/IJN.S134378","article-title":"Tumor microenvironment dual-responsive core\u2013shell nanoparticles with hyaluronic acidshield for efficient co-delivery of doxorubicin and plasmid DNA","volume":"12","author":"Wang","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2023.07.063_bb0160","doi-asserted-by":"crossref","first-page":"5828","DOI":"10.7150\/thno.34837","article-title":"Homotypic cell membrane-cloaked biomimetic nanocarrier for the targeted chemotherapy of hepatocellular carcinoma","volume":"9","author":"Liu","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2023.07.063_bb0165","doi-asserted-by":"crossref","first-page":"eaaw6870","DOI":"10.1126\/sciadv.aaw6870","article-title":"Red blood cell-derived nanoerythrosome for antigen delivery with enhanced cancer immunotherapy","volume":"5","author":"Han","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2023.07.063_bb0170","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.7150\/thno.40291","article-title":"Coating biomimetic nanoparticles with chimeric antigen receptor T cell-membrane provides high specificity for hepatocellular carcinoma photothermal therapy treatment","volume":"10","author":"Ma","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2023.07.063_bb0175","doi-asserted-by":"crossref","first-page":"32729","DOI":"10.1021\/acsami.9b10948","article-title":"Cancer cell membrane-biomimetic nanoplatform for enhanced sonodynamic therapy on breast cancer via autophagy regulation strategy","volume":"11","author":"Feng","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2023.07.063_bb0180","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.redox.2015.09.009","article-title":"Reciprocal regulation of TGF-\u03b2 and reactive oxygen species: a perverse cycle for fibrosis","volume":"6","author":"Liu","year":"2015","journal-title":"Redox Biol."},{"key":"10.1016\/j.jconrel.2023.07.063_bb0185","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1080\/10717544.2022.2032874","article-title":"Hyaluronic acid-modified redox-sensitive hybrid nanocomplex loading with siRNA for non-small-cell lung carcinoma therapy","volume":"29","author":"Chen","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2023.07.063_bb0190","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1002\/ijc.34447","article-title":"Extracellular vesicles secreted by triple negative breast cancer stem cells trigger pre-metastatic niche remodeling and metastatic growth in the lungs","volume":"152","author":"Gonz\u00e1lez-Callejo","year":"2023","journal-title":"Int. J. Cancer"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923004868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365923004868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:45:55Z","timestamp":1759164355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365923004868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":38,"alternative-id":["S0168365923004868"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.07.063","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Homotypic targeted nanoplatform enable efficient chemoimmunotherapy and reduced DOX cardiotoxicity in chemoresistant cancer via TGF-\u03b21 blockade","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2023.07.063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}